Continuous Glucose Monitoring Device (CGMD) Market Size 2031

Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), End User (Hospitals and Clinics and Self or Homecare), and Geography

Publication Month : Aug 2025

  • Report Code : TIPRE00018031
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 275
Inquire Before Buy

PRICING

$4450

$3560

Download Free Sample    Inquire for Discount   

The continuous glucose monitoring device (CGMD) market size is projected to reach US$ 33.21 billion by 2031 from US$ 12.71 billion in 2024. The market is expected to register a CAGR of 14.9% during 2025–2031.

Continuous Glucose Monitoring Device (CGMD) Market Analysis

The rising global prevalence of diabetes, technological advancements in CGMDs, and benefits over conventional glucose monitoring drive the continuous glucose monitoring device (CGMD) market growth. Additionally, integration with insulin delivery and AI-driven support contributes to market growth. Increasing accessibility in emerging and underserved markets is expected to create ample opportunities for the continuous glucose monitoring device (CGMD) market in the coming years.

Continuous Glucose Monitoring Device (CGMD) Market Overview

North America is projected to dominate the continuous glucose monitoring device (CGMD) market, accounting for the largest share during the forecast period. Moreover, Asia Pacific is expected to register a significant CAGR during the forecast period due to increasing prevalence attributed to urbanization, sedentary lifestyles, dietary changes, and technological advancements. China is confronting a considerable and escalating diabetes epidemic, with projections indicating that by 2050, the country will have ~168 million individuals living with type 2 diabetes, a substantial increase from 2024 figures (148 million), as per the data of IDF. This surge is attributed to urbanization, dietary changes, and aging demographics. The government of China has set ambitious targets to enhance diabetes awareness and management. By 2030, the National Health Commission aims to achieve a 60% awareness rate among individuals aged 18 and above and ensure that 70% of type 2 diabetes patients receive standardized management services at the local level. The growing prevalence of diabetes has spurred advancements in medical technology, particularly in continuous glucose monitoring (CGM).

In response to the growing need for effective diabetes management, the Indian healthcare system has made significant advancements in the availability and reimbursement of CGM devices. Notably, in March 2022, the Ministry of Health, Labour and Welfare (MHLW) approved the extension of reimbursement coverage for Abbott's FreeStyle Libre system to include all individuals with diabetes who use insulin at least once daily. Similarly, in December 2022, Terumo Corporation announced that the Japanese medical insurance system expanded payment coverage for the Dexcom G6 CGM System, making the device more accessible to diabetic patients in Japan. These policy changes have significantly increased the adoption of CGM devices nationwide. The growth is driven by domestic and international companies, including Dexcom, Abbott, Medtronic, and Terumo Corporation, which are actively involved in developing and distributing CGM systems in India.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Continuous Glucose Monitoring Device (CGMD) Market: Strategic Insights

continuous-glucose-monitoring-market
Market Size Value inUS$ 9.8 billion in 2022
Market Size Value byUS$ 28.5 billion by 2030
Growth rateCAGR of 14.1% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst
Continuous Glucose Monitoring Device (CGMD) Market Drivers and Opportunities

Market Drivers:

  • Rising Global Prevalence of Diabetes:

    The surge in global diabetes prevalence stands as a fundamental growth engine for the CGM market. Recent data reveal a dramatic transformation: the proportion of adults with diabetes has doubled over roughly the past three decades, climbing from ~7% in 1990 to 14% by 2022, now encompassing more than 800 million people worldwide. This puts current prevalence at ~11.1% (or one in nine adults), with projections soaring to 853 million (one in eight adults) by 2050, marking a 46% increase, per the International Diabetes Federation.

  • Growing Technological Advancements in CGM Devices:

    Technological progress in continuous glucose monitoring (CGM) drives market growth by enhancing device accuracy, user experience, and expanding potential use cases. The integration of AI-driven predictive algorithms marks another leap forward. Systems such as Medtronic's Guardian Sensor?4 can forecast glucose fluctuations up to 60 minutes ahead, enabling preemptive alerts and interventions. Broader industry trends indicate growing use of machine learning to model user-specific glucose trends, personalize alerts, and enhance interaction with other health data, pushing CGMs into truly predictive and personalized health tools.

  • Benefits Over Conventional Glucose Monitoring:

    CGMs eliminate the practical and psychological burden of frequent finger sticks, a limitation that impaired adherence and quality of life with earlier methods. Children particularly value this finger-prick-free approach, and patients undergoing intensive therapy report higher treatment satisfaction and long-term device retention rates despite cost and device complexity challenges.

Market Opportunities:

  • Increasing Accessibility in Emerging and Underserved Markets:

    A key growth opportunity in the continuous glucose monitoring (CGM) devices market lies in increasing accessibility across emerging and underserved regions, where diabetes prevalence is rising sharply. Yet, access to modern diabetes management tools remains severely limited. However, CGM penetration remains under 5% in many regions, mainly due to high upfront costs, lack of awareness, limited reimbursement, and inadequate healthcare infrastructure. This disparity presents a significant untapped opportunity for both global and local players aiming to expand their reach.

  • Expanding in Emerging Economies:

    Rapid economic growth drives investments in healthcare infrastructure and new medical technologies in countries such as China, India, and South Africa. Initiatives toward reinforcing healthcare sectors include modernizing urological care, raising awareness about early diagnosis, and expanding health insurance coverage.

  • Rising Strategic Initiatives by Market Players:

    Companies operating in the continuous glucose monitoring device (CGMD) market frequently pursue strategic initiatives such as product approvals, collaborations, funding, agreements, and new product launches, to improve their sales, increase their geographic reach, expand their customer base, and strengthen market presence.

  • Public-Private Partnerships:

    Public-private partnerships offer significant opportunities in the continuous glucose monitoring device (CGMD) market by fostering collaboration between governments and private companies to improve healthcare access. These partnerships can support the development and distribution of advanced CGM technologies, enhance funding for screening programs, and facilitate training initiatives. Such cooperation promotes innovation while expanding the availability of CGM solutions in underserved or remote regions.
 

Continuous Glucose Monitoring Device (CGMD) Market Report Segmentation Analysis

The continuous glucose monitoring device (CGMD) market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:

By Product:

  • Sensors:

    Sensors remain the technological and economic keystone of continuous glucose monitoring (CGM) systems in diabetes care. These small, wearable components are inserted subcutaneously to continuously measure interstitial glucose levels, typically at 5-minute intervals, transmitting real-time data to receivers or smartphones. The CGM sensor market has seen substantial momentum over the past few years, driven by rapid innovation, growing global diabetes prevalence, and greater adoption among Type 1 and, increasingly, Type 2 diabetes patients.

  • Transmitters:

    Transmitters are placed on the skin to communicate wirelessly with a sensor inserted beneath the skin. This sensor measures glucose levels in the interstitial fluid. The transmitter sends this data to a receiver or smartphone app, enabling users to monitor their glucose levels and receive high or low blood sugar alerts. CGM devices typically use radiofrequency transmitters, which utilize radio waves to transmit data from the sensor to the receiver or smartphone application. Near-Field Communication (NFC) and Bluetooth transmitters are also used in CGM devices.

  • Receivers:

    Receivers, the devices or interfaces that display CGM sensors' glucose readings, are a critical link between sensing and user interpretation. Yet, they often fall into the background amid the spotlight on sensors and transmitters. Recent advancements have reshaped their functionality, format, and integration within broader diabetes-care ecosystems. Historically, many CGM systems offered dedicated standalone receivers.

By Application:

  • Type 1 Diabetes
  • Type 2 Diabetes

By Testing Sites:

  • Fingertip Testing
  • Alternate Site Testing

By End User:

  • Hospitals and Clinics
  • Self or Homecare

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

The continuous glucose monitoring device (CGMD) market in North America is expected to hold a significant share of the market. Rising global prevalence of diabetes, technological advancements in CGM devices, and benefits over conventional glucose monitoring by the market players drive the market growth.

 

Continuous Glucose Monitoring Device (CGMD) Market Report ScopeContinuous Glucose Monitoring Device (CGMD) Market Share Analysis by Geography

Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in Latin America, the Middle East, and Africa also have many untapped opportunities for continuous glucose monitoring devices providers to expand.

The continuous glucose monitoring device (CGMD) market growth is attributed to the increasing prevalence of diabetes, well-established healthcare infrastructure, and rapid adoption of cutting-edge technologies. Below is a summary of market share and trends by region:

1. North America

  • Market Share:

    Holds a significant portion of the global market

  • Key Drivers:

    • Increasing prevalence of diabetes
    • Technological advancement
    • Favorable regulatory & reimbursement environment  
  •  

    Trends:

    AI Integration Across the Value Chain.

2. Europe

  • Market Share:

    Substantial share due to the increasing prevalence of diabetes

  • Key Drivers:

    • Increasing prevalence of diabetes
    • Intensified research and development activities
    • The launch of advanced technologies across Europe

  • Trends:

    Device miniaturization & smart tech integration

3. Asia Pacific

  • Market Share:

    Fastest-growing region with a rising market share every year

  • Key Drivers:

    • Demand for smart and innovative CGMDs
    • Rising prevalence of diabetes
    • Rapid improvements in healthcare infrastructure, supported by increasing government investments in public health.

  • Trends:

    Technological advancement

4. South and Central America

  • Market Share:

    Growing market with steady progress

  • Key Drivers:

    • High prevalence of diabetes
    • Growing healthcare investments and infrastructure development

  • Trends:

    Growing adoption of cutting-edge CGMD technology

5. Middle East and Africa

  • Market Share:

    Although small, but growing quickly

  • Key Drivers:

    • Expanding healthcare infrastructure
    • Increased public awareness emphasizes the importance of early diabetes condition diagnosis  

  • Trends:

    The adoption of telemedicine and remote device support  

Continuous Glucose Monitoring Device (CGMD) Market Players Density: Understanding Its Impact on Business Dynamics

 

High Market Density and Competition

Competition is strong due to the presence of established players such as Abbott Laboratories; Dexcom Inc.; Ypsomed Holding AG. Regional and niche providers such as A. Menarini Diagnostics s.r.l and Medtrum Technologies Inc. are also adding to the competitive landscape across different regions.

This high level of competition urges companies to stand out by offering:

  • Advanced Products
  • Value-added services such as customization and sustainable solutions
  • Competitive pricing models
  • Compliance with regulatory guidelines

Opportunities and Strategic Moves

  • Growing preference for innovative and advanced glucose monitoring drives demand for CGMDs. Opportunity for innovation in portable, easy-to-use monitoring devices.
  • Companies emphasize clinical studies and regulatory approvals (including FDA clearances for new product categories), building strong clinical evidence to support adoption in hospitals and outpatient settings.
  • Companies are targeting high-growth, under-penetrated markets in Asia Pacific and Latin America to expand, build local partnerships, and increase training initiatives. Manufacturers from Asia Pacific are launching hybrid and price-competitive solutions for emerging markets.

Major Companies operating in the Continuous Glucose Monitoring Device (CGMD) Market are:

  • Abbott Laboratories
  • Dexcom Inc.
  • Ypsomed Holding AG
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • Senseonics Holdings Inc
  • i-SENS Inc.
  • A. Menarini Diagnostics s.r.l
  • Tandem Diabetes Care, Inc.
  • Medtrum Technologies Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analysed during the course of research:

  • GlySens Incorporated
  • Echo Therapeutics, Inc.
  • B. Braun SE
  • Agamatrix Inc
  • PHC Holdings Corporation
  • Nemaura Medical Inc.
  • Zhejiang POCTech Co., Ltd.
  • MicroTech Medical
  • Sinocare
  • Med Trust
  • Bigfoot Biomedical Inc.
Continuous Glucose Monitoring Device (CGMD) Market News and Recent Developments

  • Tracky launches India's first bluetooth-connected continuous glucose monitor

    To tackle one of the country's most pressing health challenges, Thane-based startup Tracky, an innovative healthtech brand by DrStore Healthcare Services, has officially launched - India's first Bluetooth-enabled Continuous Glucose Monitor (CGM).

  • FDA clears Dexcom G7 15-Day continuous glucose monitor

    Dexcom announced it had received FDA clearance for its Dexcom G7 15-Day continuous glucose monitoring system for use in adults aged 18 and older. The system extends wear time to 15.5 days. It reports a mean absolute relative difference of 8.0%, making it one of the most durable and high-performing continuous glucose monitoring devices currently authorized in the US market.

Continuous Glucose Monitoring Device (CGMD) Market Report Coverage and Deliverables

The "Continuous glucose monitoring device (CGMD) market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Continuous glucose monitoring device (CGMD) market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Continuous glucose monitoring device (CGMD) market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Continuous glucose monitoring device (CGMD) market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the continuous glucose monitoring device (CGMD) market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Application, Testing Site, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

What is the expected CAGR of the continuous glucose monitoring device (CGMD) market?

The continuous glucose monitoring device (CGMD) market is estimated to register a CAGR of 14.9% during the forecast period.

Which region dominated the continuous glucose monitoring device (CGMD) market in 2024?

North America dominated the market in 2024.

What factors drive the continuous glucose monitoring device (CGMD) market?

The rising global prevalence of diabetes, technological advancements in CGM devices, and benefits over conventional glucose monitoring are among the factors contributing to market growth.

Which are the leading players in the continuous glucose monitoring device (CGMD) market?

Abbott Laboratories; Dexcom Inc.; Ypsomed Holding AG; Medtronic; F. Hoffmann-La Roche Ltd; Senseonics Holdings Inc; i-SENS Inc.; A. Menarini Diagnostics s.r.l; Tandem Diabetes Care, Inc.; and Medtrum Technologies Inc. are among the key players operating in the Continuous glucose monitoring device (CGMD) market.

What would be the estimated value of the continuous glucose monitoring device (CGMD) market by 2031?

The continuous glucose monitoring device (CGMD) market is estimated to reach US$ 33.21 Billion by 2031.

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

3.3 Assumptions and Limitations

4. Continuous Glucose Monitoring Device (CGMD) Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Continuous Glucose Monitoring Device (CGMD) Market – Key Market Dynamics

5.1 Continuous Glucose Monitoring Device (CGMD) Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Global Prevalence of Diabetes

5.2.2 Growing Technological Advancements in CGM Devices

5.2.3 Benefits Over Conventional Glucose Monitoring

5.3 Market Restraints

5.3.1 High Cost and Limited Reimbursement

5.3.2 User Comfort and Wearability Challenges

5.4 Market Opportunities

5.4.1 Increasing Accessibility in Emerging and Underserved Markets

5.5 Future Trends

5.5.1 Integration with Insulin Delivery and AI-Driven Decision Support

5.6 Impact of Drivers and Restraints:

6. Continuous Glucose Monitoring Device (CGMD) Market – Global Market Analysis

6.1 Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2021–2031

6.2 Continuous Glucose Monitoring Device (CGMD) Market Forecast Analysis

7. Continuous Glucose Monitoring Device (CGMD) Market Analysis – by Product

7.1 Sensors

7.1.1 Overview

7.1.2 Sensors: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Transmitters

7.2.1 Overview

7.2.2 Transmitters: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Receivers

7.3.1 Overview

7.3.2 Receivers: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

8. Continuous Glucose Monitoring Device (CGMD) Market Analysis – by Application

8.1 Type 1 Diabetes

8.1.1 Overview

8.1.2 Type 1 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Type 2 Diabetes

8.2.1 Overview

8.2.2 Type 2 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

9. Continuous Glucose Monitoring Device (CGMD) Market Analysis – by Testing Sites

9.1 Fingertip Testing

9.1.1 Overview

9.1.2 Fingertip Testing: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Alternate Site Testing

9.2.1 Overview

9.2.2 Alternate Site Testing: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

10. Continuous Glucose Monitoring Device (CGMD) Market Analysis – by End User

10.1 Hospitals and Clinics

10.1.1 Overview

10.1.2 Hospitals and Clinics: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

10.2 Self or Homecare

10.2.1 Overview

10.2.2 Self or Homecare: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

11. Continuous Glucose Monitoring Device (CGMD) Market – Geographical Analysis

11.1 Overview

11.2 North America

11.2.1 North America Continuous Glucose Monitoring Device (CGMD) Market Overview

11.2.2 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

11.2.3 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.2.3.1 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Product

11.2.4 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.2.4.1 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Application

11.2.5 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.2.5.1 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Testing Sites

11.2.6 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.2.6.1 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by End User

11.2.7 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.2.7.1 North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.2.7.2 United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.2.7.2.1 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.2.7.2.2 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.2.7.2.3 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.2.7.2.4 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.2.7.3 Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.2.7.3.1 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.2.7.3.2 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.2.7.3.3 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.2.7.3.4 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.2.7.4 Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.2.7.4.1 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.2.7.4.2 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.2.7.4.3 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.2.7.4.4 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3 Europe

11.3.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Overview

11.3.2 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

11.3.3 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.3.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Product

11.3.4 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.4.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Application

11.3.5 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.5.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Testing Sites

11.3.6 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3.6.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by End User

11.3.7 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.3.7.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.3.7.2 Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.2.1 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.7.2.2 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.7.2.3 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.7.2.4 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3.7.3 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.3.1 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.7.3.2 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.7.3.3 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.7.3.4 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3.7.4 France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.4.1 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.7.4.2 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.7.4.3 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.7.4.4 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3.7.5 Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.5.1 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.7.5.2 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.7.5.3 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.7.5.4 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3.7.6 Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.6.1 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.7.6.2 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.7.6.3 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.7.6.4 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.3.7.7 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.3.7.7.1 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.3.7.7.2 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.3.7.7.3 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.3.7.7.4 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4 Asia Pacific

11.4.1 Asia Pacific Continuous Glucose Monitoring Device (CGMD) Market Overview

11.4.2 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

11.4.3 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.3.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Product

11.4.4 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.4.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Application

11.4.5 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.5.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Testing Sites

11.4.6 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4.6.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by End User

11.4.7 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.4.7.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.4.7.2 China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.2.1 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.7.2.2 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.7.2.3 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.7.2.4 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4.7.3 India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.3.1 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.7.3.2 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.7.3.3 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.7.3.4 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4.7.4 Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.4.1 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.7.4.2 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.7.4.3 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.7.4.4 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4.7.5 South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.5.1 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.7.5.2 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.7.5.3 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.7.5.4 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4.7.6 Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.6.1 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.7.6.2 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.7.6.3 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.7.6.4 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.4.7.7 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.4.7.7.1 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.4.7.7.2 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.4.7.7.3 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.4.7.7.4 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.5 Middle East and Africa

11.5.1 Middle East and Africa Continuous Glucose Monitoring Device (CGMD) Market Overview

11.5.2 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

11.5.3 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.5.3.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Product

11.5.4 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.5.4.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Application

11.5.5 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.5.5.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Testing Sites

11.5.6 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.5.6.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by End User

11.5.7 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.5.7.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.5.7.2 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.2.1 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.5.7.2.2 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.5.7.2.3 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.5.7.2.4 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.5.7.3 South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.3.1 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.5.7.3.2 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.5.7.3.3 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.5.7.3.4 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.5.7.4 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.4.1 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.5.7.4.2 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.5.7.4.3 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.5.7.4.4 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.5.7.5 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.5.7.5.1 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.5.7.5.2 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.5.7.5.3 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.5.7.5.4 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.6 South and Central America

11.6.1 South and Central America Continuous Glucose Monitoring Device (CGMD) Market Overview

11.6.2 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

11.6.3 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.6.3.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Product

11.6.4 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.6.4.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Application

11.6.5 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.6.5.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Testing Sites

11.6.6 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.6.6.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by End User

11.6.7 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.6.7.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast Analysis – by Country

11.6.7.2 Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.6.7.2.1 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.6.7.2.2 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.6.7.2.3 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.6.7.2.4 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.6.7.3 Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.6.7.3.1 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.6.7.3.2 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.6.7.3.3 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.6.7.3.4 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

11.6.7.4 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.6.7.4.1 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product

11.6.7.4.2 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application

11.6.7.4.3 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites

11.6.7.4.4 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players

12.2 Company Positioning & Concentration

13. Global Continuous Glucose Monitoring Device Market Industry Landscape

13.1 Overview

13.2 Product Launch, Product Approvals

13.3 Expansions And Other Strategic Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Dexcom Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Ypsomed Holding AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Medtronic Plc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 F. Hoffmann-La Roche Ltd

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Senseonics Holdings Inc

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 i-SENS Inc

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 A. Menarini Diagnostics s.r.l

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Tandem Diabetes Care Inc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Medtrum Technologies Inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 List of Abbreviations

List of Tables

Table 1. Continuous Glucose Monitoring Device (CGMD) Market Segmentation

Table 2. Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million)

Table 3. Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 4. Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 5. Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 6. Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 7. Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 8. Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 9. Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 10. Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 11. Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 12. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 13. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 14. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 15. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 16. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 17. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 18. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 19. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 20. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 21. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 22. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 23. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 24. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 25. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 26. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 27. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 28. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 29. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 30. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 31. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 32. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 33. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 34. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 35. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 36. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 37. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 38. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 39. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 40. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 41. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 42. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 43. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 44. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 45. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 46. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 47. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 48. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 49. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 50. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 51. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 52. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 53. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 54. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 55. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 56. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 57. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 58. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 59. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 60. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 61. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 62. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 63. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 64. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 65. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 66. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 67. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 68. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 69. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 70. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 71. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 72. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 73. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 74. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 75. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 76. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 77. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 78. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 79. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 80. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 81. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 82. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 83. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 84. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 85. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 86. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 87. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 88. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 89. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 90. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 91. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 92. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 93. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 94. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 95. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 96. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 97. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 98. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 99. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 100. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 101. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 102. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 103. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 104. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 105. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 106. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 107. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 108. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 109. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 110. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 111. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 112. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 113. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 114. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 115. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 116. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 117. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 118. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 119. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 120. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 121. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 122. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 123. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 124. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 125. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 126. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 127. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 128. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 129. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 130. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 131. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 132. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 133. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 134. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 135. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 136. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 137. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 138. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 139. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 140. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 141. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 142. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 143. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 144. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 145. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 146. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 147. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 148. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 149. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 150. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 151. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 152. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 153. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 154. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 155. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 156. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 157. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 158. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 159. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 160. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 161. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 162. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 163. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 164. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 165. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 166. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 167. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 168. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 169. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 170. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 171. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 172. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 173. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 174. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 175. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 176. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 177. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 178. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 179. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 180. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 181. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 182. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 183. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 184. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 185. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 186. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 187. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 188. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 189. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 190. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 191. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 192. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 193. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 194. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 195. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 196. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 197. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 198. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 199. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 200. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 201. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 202. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 203. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 204. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 205. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 206. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 207. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 208. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 209. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 210. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 211. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 212. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 213. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 214. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 215. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 216. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 217. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 218. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 219. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 220. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 221. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 222. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 223. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 224. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 225. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 226. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 227. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 228. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 229. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 230. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Product

Table 231. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product

Table 232. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 233. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 234. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by Testing Sites

Table 235. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by Testing Sites

Table 236. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 237. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 238. Heat Map Analysis by Key Players

Table 239. List of Abbreviations

List of Figures

Figure 1. Continuous Glucose Monitoring Device (CGMD) Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2021–2031

Figure 5. Continuous Glucose Monitoring Device (CGMD) Market Share (%) – by Product (2024 and 2031)

Figure 6. Sensors: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Transmitters: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Receivers: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Continuous Glucose Monitoring Device (CGMD) Market Share (%) – by Application (2024 and 2031)

Figure 10. Type 1 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Type 2 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Continuous Glucose Monitoring Device (CGMD) Market Share (%) – by Testing Sites (2024 and 2031)

Figure 13. Fingertip Testing: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Alternate Site Testing: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Continuous Glucose Monitoring Device (CGMD) Market Share (%) – by End User (2024 and 2031)

Figure 16. Hospitals and Clinics: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Self or Homecare: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Region, 2024 and 2031 (%)

Figure 19. North America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

Figure 20. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)

Figure 21. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)

Figure 22. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)

Figure 23. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)

Figure 24. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 25. United States: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 26. Canada: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 27. Mexico: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 28. Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

Figure 29. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)

Figure 30. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)

Figure 31. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)

Figure 32. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)

Figure 33. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 34. Germany: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 35. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 36. France: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 37. Italy: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 38. Spain: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 39. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 40. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

Figure 41. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)

Figure 42. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)

Figure 43. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)

Figure 44. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)

Figure 45. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 46. China: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 47. India: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 48. Japan: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 49. South Korea: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 50. Australia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 51. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 52. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

Figure 53. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)

Figure 54. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)

Figure 55. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)

Figure 56. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)

Figure 57. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 58. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 59. South Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 60. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 61. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 62. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue, 2021–2031 (US$ Million)

Figure 63. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)

Figure 64. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)

Figure 65. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)

Figure 66. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)

Figure 67. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 68. Brazil: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 69. Argentina: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 70. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 71. Company Positioning & Concentration

The List of companies - Continuous Glucose Monitoring Device (CGMD) Market

  1. Abbott Laboratories
  2. Dexcom Inc.
  3. Ypsomed Holding AG
  4. Medtronic
  5. F. Hoffmann-La Roche Ltd
  6. Senseonics Holdings Inc
  7. i-SENS Inc.
  8. A. Menarini Diagnostics s.r.l
  9. Tandem Diabetes Care, Inc.
  10. Medtrum Technologies Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Continuous Glucose Monitoring Device (CGMD) Market

Cover Image

Aug 2025

Wheelchair and Mobility Aids Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)

[read more] GET SAMPLE   
Cover Image

Aug 2025

Cystoscopy and Ureteroscopy Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)

[read more] GET SAMPLE   
Cover Image

Aug 2025

Cancer Drugs Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Other Therapy Types), By Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Ducts Cancer, Thyroid Cancer, and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and Geography

[read more] GET SAMPLE   
Cover Image

Aug 2025

Walking Aids Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Canes, Crutches, Walkers, Rollators, and Others), Age Group (Adults and Pediatric), Application (Neurologically Impaired, Handicap Patients, and Others), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)

[read more] GET SAMPLE   
Cover Image

Aug 2025

Infectious Disease In vitro Diagnostics Market

Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography

[read more] GET SAMPLE   
Cover Image

Aug 2025

Donor Blood Components Market

Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography

[read more] GET SAMPLE   
Cover Image

Aug 2025

Aesthetic Injectable Devices Market

Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography

[read more] GET SAMPLE   
Cover Image

Aug 2025

ECG Monitoring Equipment Market

Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

[read more] GET SAMPLE